Literature DB >> 14732793

Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia.

Mustafa Kolsuz1, Sinan Erginel, Ozkan Alataş, Füsun Alataş, Muzaffer Metintaş, Irfan Uçgun, Emel Harmanci, Omer Colak.   

Abstract

BACKGROUND: Bacterial infection of the lower respiratory tract initiates an acute inflammatory response. Regulation of the inflammatory response in bacterial pneumonia depends on a complex interaction between immune cells and inflammatory cytokines.
OBJECTIVES: We investigated the initial levels of proinflammatory cytokines and acute phase reactants (APR), e.g. C-reactive protein (CRP), upon presentation of community-acquired pneumonia (CAP) in relation to clinical and laboratory indices of infection.
METHODS: We prospectively studied 28 consecutive patients with unilateral CAP. Tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1beta, IL-6 and IL-8 concentrations were measured by ELISA in both bronchoalveolar lavage (BAL) fluid and serum.
RESULTS: The concentrations of IL1-beta and IL-6 in BAL fluid were found to be significantly higher in the involved lung than those in either the uninvolved lung (p = 0.008 and p = 0.012, respectively) or serum (p = 0.002 and p = 0.025, respectively). Serum CRP concentrations were increased compared to those in the involved and uninvolved lung in BAL fluid (p = 0.000 and p = 0.000, respectively). In serum and BAL from involved lung, IL-6 concentrations were higher in the systemic inflammatory response syndrome (SIRS) group than in the non-SIRS group (p < 0.05), whereas CRP, TNF-alpha, IL-1beta and IL-8 concentrations showed no difference between SIRS and non-SIRS. There was no significant correlation between the acute physiology and chronic health evaluation II score and the cytokines.
CONCLUSIONS: Our results indicate that the CRP level is higher in the serum than in the BAL fluid in the lung, and that IL-6 is the most important cytokine for the determination of the severity of the disease. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14732793     DOI: 10.1159/000075208

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  10 in total

1.  Inhibitory effects and related molecular mechanisms of total flavonoids in Mosla chinensis Maxim against H1N1 influenza virus.

Authors:  Xiao-Xia Zhang; Qiao-Feng Wu; Yun-Liang Yan; Feng-Ling Zhang
Journal:  Inflamm Res       Date:  2017-11-24       Impact factor: 4.575

2.  Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia.

Authors:  Matthew R Jones; Lee J Quinton; Benjamin T Simms; Michal M Lupa; Mariya S Kogan; Joseph P Mizgerd
Journal:  J Infect Dis       Date:  2005-12-27       Impact factor: 5.226

3.  Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates.

Authors:  Bryan D Kraft; Claude A Piantadosi; Ashlee M Benjamin; Joseph E Lucas; Aimee K Zaas; Marisol Betancourt-Quiroz; Christopher W Woods; Alan L Chang; Victor L Roggli; Craig D Marshall; Geoffrey S Ginsburg; Karen Welty-Wolf
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

4.  Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice.

Authors:  Janhavi Athale; Allison Ulrich; Nancy Chou MacGarvey; Raquel R Bartz; Karen E Welty-Wolf; Hagir B Suliman; Claude A Piantadosi
Journal:  Free Radic Biol Med       Date:  2012-08-23       Impact factor: 7.376

5.  Baicalin relieves Mycoplasma pneumoniae infection‑induced lung injury through regulating microRNA‑221 to inhibit the TLR4/NF‑κB signaling pathway.

Authors:  Han Zhang; Xiang Li; Juan Wang; Qi Cheng; Yunxiao Shang; Guizhen Wang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

6.  Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ.

Authors:  Katrin Zobel; Peter Martus; Mathias W Pletz; Santiago Ewig; Michael Prediger; Tobias Welte; Frank Bühling
Journal:  BMC Pulm Med       Date:  2012-02-20       Impact factor: 3.317

7.  Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].

Authors:  Mirjam Christ-Crain; Nils G Morgenthaler; Daiana Stolz; Christian Müller; Roland Bingisser; Stephan Harbarth; Michael Tamm; Joachim Struck; Andreas Bergmann; Beat Müller
Journal:  Crit Care       Date:  2006-06-28       Impact factor: 9.097

8.  The balance between the serum levels of IL-6 and IL-10 cytokines discriminates mild and severe acute pneumonia.

Authors:  Rita de Cássia Coelho Moraes de Brito; Norma Lucena-Silva; Leuridan Cavalcante Torres; Carlos Feitosa Luna; Jaílson de Barros Correia; Giselia Alves Pontes da Silva
Journal:  BMC Pulm Med       Date:  2016-12-01       Impact factor: 3.317

9.  Clinical characteristics and cytokine changes in children with pneumonia requiring mechanical ventilation.

Authors:  Thuy Nguyen Thi Dieu; An Pham Nhat; Timothy J Craig; Sy Duong-Quy
Journal:  J Int Med Res       Date:  2017-01-12       Impact factor: 1.671

10.  Cytokines and chemokines as biomarkers of community-acquired bacterial infection.

Authors:  Michal Holub; David A Lawrence; Nancy Andersen; Alžběta Davidová; Ondřej Beran; Vilma Marešová; Pavel Chalupa
Journal:  Mediators Inflamm       Date:  2013-04-16       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.